annual CFF:
$659.51M+$650.60M(+7300.21%)Summary
- As of today (September 17, 2025), NAMS annual cash flow from financing activities is $659.51 million, with the most recent change of +$650.60 million (+7300.21%) on December 31, 2024.
- During the last 3 years, NAMS annual CFF has risen by +$574.80 million (+678.60%).
- NAMS annual CFF is now at all-time high.
Performance
NAMS Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$3.42M-$3.09M(-47.46%)Summary
- As of today (September 17, 2025), NAMS quarterly cash flow from financing activities is $3.42 million, with the most recent change of -$3.09 million (-47.46%) on June 30, 2025.
- Over the past year, NAMS quarterly CFF has dropped by -$1.23 million (-26.47%).
- NAMS quarterly CFF is now -99.25% below its all-time high of $456.61 million, reached on December 31, 2024.
Performance
NAMS quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$466.61M-$1.23M(-0.26%)Summary
- As of today (September 17, 2025), NAMS TTM cash flow from financing activities is $466.61 million, with the most recent change of -$1.23 million (-0.26%) on June 30, 2025.
- Over the past year, NAMS TTM CFF has increased by +$263.77 million (+130.04%).
- NAMS TTM CFF is now -29.25% below its all-time high of $659.51 million, reached on December 31, 2024.
Performance
NAMS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
NAMS Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7300.2% | -26.5% | +130.0% |
| 3 y3 years | +678.6% | +100.0% | +10000.0% |
| 5 y5 years | +4636.8% | - | - |
NAMS Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7300.2% | -99.3% | >+9999.0% | -29.3% | >+9999.0% |
| 5 y | 5-year | at high | +7300.2% | -99.3% | +7711.1% | -29.3% | >+9999.0% |
| alltime | all time | at high | +7300.2% | -99.3% | +7711.1% | -29.3% | >+9999.0% |
NAMS Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $3.42M(-47.5%) | $466.61M(-0.3%) |
| Mar 2025 | - | $6.52M(-98.6%) | $467.85M(-29.1%) |
| Dec 2024 | $659.51M(+7300.2%) | $456.61M(>+9900.0%) | $659.51M(+225.0%) |
| Sep 2024 | - | $58.00K(-98.8%) | $202.90M(+0.0%) |
| Jun 2024 | - | $4.66M(-97.6%) | $202.84M(+2.4%) |
| Mar 2024 | - | $198.18M(+8185.1%) | $198.18M(+8185.1%) |
| Dec 2023 | $8.91M(-97.7%) | - | - |
| Mar 2023 | - | $2.39M | $2.39M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $391.90M(+362.7%) | - | - |
| Sep 2022 | - | $0.00(0.0%) | -$45.00K(0.0%) |
| Jun 2022 | - | $0.00(-100.0%) | -$45.00K(0.0%) |
| Mar 2022 | - | -$45.00K(<-9900.0%) | -$45.00K(<-9900.0%) |
| Dec 2021 | $84.70M(+508.4%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2021 | - | $0.00 | $0.00 |
| Dec 2020 | $13.92M | - | - |
FAQ
- What is NewAmsterdam Pharma Company N.V. annual cash flow from financing activities?
- What is the all time high annual CFF for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. annual CFF year-on-year change?
- What is NewAmsterdam Pharma Company N.V. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. quarterly CFF year-on-year change?
- What is NewAmsterdam Pharma Company N.V. TTM cash flow from financing activities?
- What is the all time high TTM CFF for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. TTM CFF year-on-year change?
What is NewAmsterdam Pharma Company N.V. annual cash flow from financing activities?
The current annual CFF of NAMS is $659.51M
What is the all time high annual CFF for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high annual cash flow from financing activities is $659.51M
What is NewAmsterdam Pharma Company N.V. annual CFF year-on-year change?
Over the past year, NAMS annual cash flow from financing activities has changed by +$650.60M (+7300.21%)
What is NewAmsterdam Pharma Company N.V. quarterly cash flow from financing activities?
The current quarterly CFF of NAMS is $3.42M
What is the all time high quarterly CFF for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high quarterly cash flow from financing activities is $456.61M
What is NewAmsterdam Pharma Company N.V. quarterly CFF year-on-year change?
Over the past year, NAMS quarterly cash flow from financing activities has changed by -$1.23M (-26.47%)
What is NewAmsterdam Pharma Company N.V. TTM cash flow from financing activities?
The current TTM CFF of NAMS is $466.61M
What is the all time high TTM CFF for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high TTM cash flow from financing activities is $659.51M
What is NewAmsterdam Pharma Company N.V. TTM CFF year-on-year change?
Over the past year, NAMS TTM cash flow from financing activities has changed by +$263.77M (+130.04%)